BioLight Life Sciences Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	0.22	0.12	0.06	0
Revenue Growth (YoY)	-	85.59%	87.30%	2000.00%	-90.32%
Gross Profit	-	0.22	0.12	0.06	0
Selling, General & Admin	10.15	6.66	6.25	6.86	6.27
Research & Development	5.06	3.67	4.52	3.53	4.34
Operating Expenses	15.21	10.34	10.77	10.39	10.61
Operating Income	-15.21	-10.12	-10.65	-10.32	-10.6
Interest Expense	-0.08	-0.08	-0.08	-0.07	-0.02
Interest & Investment Income	0.18	0.06	0.26	0.01	0.07
Earnings From Equity Investments	-0.46	-0.29	-0.39	-0.63	-0.28
Currency Exchange Gain (Loss)	-0.23	-0.31	0.04	0.57	-0.88
Other Non Operating Income (Expenses)	0.14	-0.17	-0.96	0.3	-0.27
EBT Excluding Unusual Items	-15.66	-10.92	-11.77	-10.14	-11.98
Gain (Loss) on Sale of Investments	-1.25	2.49	-15.72	1.45	10.07
Pretax Income	-16.91	-8.42	-27.49	-8.69	-1.91
Income Tax Expense	-	-	-	-	-1.57
Earnings From Continuing Operations	-16.91	-8.42	-27.49	-8.69	-0.34
Net Income to Company	-16.91	-8.42	-27.49	-8.69	-0.34
Minority Interest in Earnings	5.18	1.28	1.47	0.84	0.72
Net Income	-11.73	-7.14	-26.02	-7.85	0.38
Net Income to Common	-11.73	-7.14	-26.02	-7.85	0.38
Shares Outstanding (Basic)	6	5	5	5	5
Shares Outstanding (Diluted)	6	5	5	5	5
Shares Change (YoY)	27.27%	0.29%	1.70%	-0.41%	0.94%
EPS (Basic)	-1.98	-1.53	-5.60	-1.72	0.08
EPS (Diluted)	-1.98	-1.53	-5.60	-1.72	0.08
Free Cash Flow	-10.86	-11.02	-10.99	-9.57	-10.63
Free Cash Flow Per Share	-1.83	-2.37	-2.37	-2.10	-2.32
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-4619.64%	-9026.27%	-16384.13%	-353433.33%
Profit Margin	-	-3261.19%	-22050.85%	-12455.56%	12733.33%
Free Cash Flow Margin	-	-5032.88%	-9315.25%	-15193.65%	-354333.33%
EBITDA	-15.17	-10.06	-10.08	-9.73	-10.07
D&A For EBITDA	0.03	0.06	0.57	0.59	0.53
EBIT	-15.21	-10.12	-10.65	-10.32	-10.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.